Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir
about
Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir
description
scientific article published on 24 October 2019
@en
wetenschappelijk artikel
@nl
name
Hepatitis B surface antigen re ...... ir administration to tenofovir
@en
Hepatitis B surface antigen re ...... ir administration to tenofovir
@nl
type
label
Hepatitis B surface antigen re ...... ir administration to tenofovir
@en
Hepatitis B surface antigen re ...... ir administration to tenofovir
@nl
prefLabel
Hepatitis B surface antigen re ...... ir administration to tenofovir
@en
Hepatitis B surface antigen re ...... ir administration to tenofovir
@nl
P2093
P356
P1476
Hepatitis B surface antigen re ...... ir administration to tenofovir
@en
P2093
Chiaki Maeyashiki
Hiroyuki Nakanishi
Jun Itakura
Kaoru Tsuchiya
Kenta Takaura
Koji Yamashita
Leona Osawa
Masayuki Kurosaki
Mayu Higuchi
P304
P356
10.1002/JGH3.12273
P50
P577
2019-10-24T00:00:00Z